๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy

โœ Scribed by Ludwig E. Smeele; Charles R. Leemans; Johannes A. Langendijk; Rammohan Tiwari; Ben J. Slotman; Isaac van der Waal; Gordon B. Snow


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
105 KB
Volume
22
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Immunoglobulin allotypes in patients wit
โœ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 1 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant

Detection of chromosomal aberrations in
โœ Veltman, Joris A. ;Hopman, Anton H.๏ฟฝN. ;Bot, Fredrik J. ;Ramaekers, Frans C.๏ฟฝS. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB ๐Ÿ‘ 1 views

## Background: Detection of genetic changes in the mucosa of the upper aerodigestive tract may provide a target for the screening of cytologic specimens to identify premalignant transformation in this region. in this pilot study, the feasibility of the fluorescence in situ hybridization (fish) tech

Radiotherapeutic management of bulky cer
โœ Christopher R. Johnson; Larry N. Silverman; Louise B. Clay; Rupert Schmidt-Ullri ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 1 views

Although traditional recommendations for the management of bulky cervical lymphadenopathy (AJCC categories N2-3) with definitive radiotherapy call for postradiotherapy neck dissection regardless of treatment response, recent data suggests that this policy can be modified on the basis of tumor regres